Immune cells for advanced melanoma
Treatments studied
Part of Cancer, Eyes & vision, Skin clinical trials.
This trial tests a treatment using your own immune cells to fight advanced melanoma. The cells are taken from a tumor, grown in a lab, and given back to you either near the tumor or throughout your body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have stage IV melanoma that has gotten worse after standard treatments.
- You have at least one tumor in the liver that can be removed for the treatment.
- You have tumors that can be measured on a CT scan.
- You are generally well enough to participate (WHO performance status 0 or 1).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses your own immune cells (called TILs) to fight melanoma that has spread to the liver. Doctors will remove a piece of the tumor, grow the immune cells in a lab, and give them back to you to help shrink the cancer.
This trial tests using your own immune cells (TILs) to fight advanced uveal melanoma, undifferentiated pleomorphic sarcoma, dedifferentiated liposarcoma, or angiosarcoma. It aims to see if this treatment can shrink tumors or slow their growth.
This trial tests a treatment made from your own immune cells (called tumor-infiltrating lymphocytes). The cells are taken from a tumor sample, multiplied in a lab, and given back to you to help fight the cancer. It's for people with melanoma that has not responded to standard immunotherapy.
This trial tests a treatment that uses your own immune cells, called tumor-infiltrating lymphocytes (TILs), to fight melanoma. Some participants also get a drug called pembrolizumab. The goal is to see if this approach can shrink tumors.
This study tests a new type of cell therapy made from your own immune cells (called TILs) to see if it can shrink tumors better than standard chemotherapy in people with advanced melanoma that has stopped responding to immunotherapy. If you qualify, you may have a chance to try a personalized treatment that uses your body's own defenses to fight the cancer.
This trial tests a new T-cell therapy made from your own tumor (TILs), genetically edited to remove the PD1 checkpoint blocker. It may help your immune system fight melanoma that has not responded to standard treatments like anti-PD1 therapy.
Hear when a new Metastatic Uveal Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.